Calcium in PDB 8tpn: NHTMEM16 Lipid Scramblase in Lipid Nanodiscs with MSP2N2 Scaffold Protein in the Presence of CA2+ (Intermediate State)
Calcium Binding Sites:
The binding sites of Calcium atom in the NHTMEM16 Lipid Scramblase in Lipid Nanodiscs with MSP2N2 Scaffold Protein in the Presence of CA2+ (Intermediate State)
(pdb code 8tpn). This binding sites where shown within
5.0 Angstroms radius around Calcium atom.
In total 4 binding sites of Calcium where determined in the
NHTMEM16 Lipid Scramblase in Lipid Nanodiscs with MSP2N2 Scaffold Protein in the Presence of CA2+ (Intermediate State), PDB code: 8tpn:
Jump to Calcium binding site number:
1;
2;
3;
4;
Calcium binding site 1 out
of 4 in 8tpn
Go back to
Calcium Binding Sites List in 8tpn
Calcium binding site 1 out
of 4 in the NHTMEM16 Lipid Scramblase in Lipid Nanodiscs with MSP2N2 Scaffold Protein in the Presence of CA2+ (Intermediate State)
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 1 of NHTMEM16 Lipid Scramblase in Lipid Nanodiscs with MSP2N2 Scaffold Protein in the Presence of CA2+ (Intermediate State) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca801
b:32.4
occ:1.00
|
OE2
|
A:GLU535
|
2.3
|
17.6
|
1.0
|
OD1
|
A:ASP503
|
2.4
|
15.7
|
1.0
|
OE1
|
A:GLU452
|
2.5
|
30.9
|
1.0
|
OD1
|
A:ASP539
|
2.6
|
19.2
|
1.0
|
OE2
|
A:GLU452
|
2.8
|
30.9
|
1.0
|
CD
|
A:GLU452
|
2.9
|
30.9
|
1.0
|
NZ
|
A:LYS542
|
3.2
|
21.7
|
1.0
|
CG
|
A:ASP539
|
3.3
|
19.2
|
1.0
|
OD2
|
A:ASP539
|
3.3
|
19.2
|
1.0
|
CD
|
A:GLU535
|
3.5
|
17.6
|
1.0
|
CG
|
A:ASP503
|
3.6
|
15.7
|
1.0
|
OE1
|
A:GLU506
|
3.6
|
14.7
|
1.0
|
CG
|
A:GLU452
|
4.2
|
30.9
|
1.0
|
OE1
|
A:GLU535
|
4.3
|
17.6
|
1.0
|
CD
|
A:GLU506
|
4.3
|
14.7
|
1.0
|
OD2
|
A:ASP503
|
4.3
|
15.7
|
1.0
|
CE
|
A:LYS542
|
4.4
|
21.7
|
1.0
|
CG
|
A:GLU535
|
4.6
|
17.6
|
1.0
|
OE2
|
A:GLU506
|
4.6
|
14.7
|
1.0
|
CB
|
A:ASP503
|
4.7
|
15.7
|
1.0
|
CB
|
A:ASP539
|
4.8
|
19.2
|
1.0
|
CA
|
A:ASP503
|
4.9
|
15.7
|
1.0
|
OD1
|
A:ASN448
|
4.9
|
29.3
|
1.0
|
OH
|
A:TYR188
|
5.0
|
11.9
|
1.0
|
|
Calcium binding site 2 out
of 4 in 8tpn
Go back to
Calcium Binding Sites List in 8tpn
Calcium binding site 2 out
of 4 in the NHTMEM16 Lipid Scramblase in Lipid Nanodiscs with MSP2N2 Scaffold Protein in the Presence of CA2+ (Intermediate State)
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 2 of NHTMEM16 Lipid Scramblase in Lipid Nanodiscs with MSP2N2 Scaffold Protein in the Presence of CA2+ (Intermediate State) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca802
b:20.8
occ:1.00
|
OE1
|
A:GLU535
|
2.3
|
17.6
|
1.0
|
ND2
|
A:ASN448
|
2.4
|
29.3
|
1.0
|
CG
|
A:ASN448
|
2.8
|
29.3
|
1.0
|
CD
|
A:GLU535
|
3.4
|
17.6
|
1.0
|
OD1
|
A:ASN448
|
3.4
|
29.3
|
1.0
|
CB
|
A:ASN448
|
3.5
|
29.3
|
1.0
|
OD1
|
A:ASN531
|
3.6
|
18.4
|
1.0
|
O
|
A:ASN448
|
3.7
|
29.3
|
1.0
|
OE2
|
A:GLU535
|
3.8
|
17.6
|
1.0
|
OE1
|
A:GLU452
|
3.9
|
30.9
|
1.0
|
ND2
|
A:ASN531
|
4.1
|
18.4
|
1.0
|
C
|
A:ASN448
|
4.2
|
29.3
|
1.0
|
CG
|
A:ASN531
|
4.3
|
18.4
|
1.0
|
OE1
|
A:GLU506
|
4.4
|
14.7
|
1.0
|
CA
|
A:ASN448
|
4.4
|
29.3
|
1.0
|
CG
|
A:GLU535
|
4.6
|
17.6
|
1.0
|
CB
|
A:GLU535
|
4.8
|
17.6
|
1.0
|
CD
|
A:GLU452
|
4.9
|
30.9
|
1.0
|
N
|
A:PHE449
|
5.0
|
31.0
|
1.0
|
|
Calcium binding site 3 out
of 4 in 8tpn
Go back to
Calcium Binding Sites List in 8tpn
Calcium binding site 3 out
of 4 in the NHTMEM16 Lipid Scramblase in Lipid Nanodiscs with MSP2N2 Scaffold Protein in the Presence of CA2+ (Intermediate State)
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 3 of NHTMEM16 Lipid Scramblase in Lipid Nanodiscs with MSP2N2 Scaffold Protein in the Presence of CA2+ (Intermediate State) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca801
b:32.4
occ:1.00
|
OE2
|
B:GLU535
|
2.3
|
17.6
|
1.0
|
OD1
|
B:ASP503
|
2.4
|
15.7
|
1.0
|
OE1
|
B:GLU452
|
2.5
|
30.9
|
1.0
|
OD1
|
B:ASP539
|
2.6
|
19.2
|
1.0
|
OE2
|
B:GLU452
|
2.8
|
30.9
|
1.0
|
CD
|
B:GLU452
|
2.9
|
30.9
|
1.0
|
NZ
|
B:LYS542
|
3.2
|
21.7
|
1.0
|
CG
|
B:ASP539
|
3.3
|
19.2
|
1.0
|
OD2
|
B:ASP539
|
3.3
|
19.2
|
1.0
|
CD
|
B:GLU535
|
3.5
|
17.6
|
1.0
|
CG
|
B:ASP503
|
3.6
|
15.7
|
1.0
|
OE1
|
B:GLU506
|
3.6
|
14.7
|
1.0
|
CG
|
B:GLU452
|
4.2
|
30.9
|
1.0
|
OE1
|
B:GLU535
|
4.3
|
17.6
|
1.0
|
CD
|
B:GLU506
|
4.3
|
14.7
|
1.0
|
OD2
|
B:ASP503
|
4.3
|
15.7
|
1.0
|
CE
|
B:LYS542
|
4.4
|
21.7
|
1.0
|
CG
|
B:GLU535
|
4.6
|
17.6
|
1.0
|
OE2
|
B:GLU506
|
4.6
|
14.7
|
1.0
|
CB
|
B:ASP503
|
4.7
|
15.7
|
1.0
|
CB
|
B:ASP539
|
4.8
|
19.2
|
1.0
|
CA
|
B:ASP503
|
4.9
|
15.7
|
1.0
|
OD1
|
B:ASN448
|
4.9
|
29.3
|
1.0
|
OH
|
B:TYR188
|
5.0
|
11.9
|
1.0
|
|
Calcium binding site 4 out
of 4 in 8tpn
Go back to
Calcium Binding Sites List in 8tpn
Calcium binding site 4 out
of 4 in the NHTMEM16 Lipid Scramblase in Lipid Nanodiscs with MSP2N2 Scaffold Protein in the Presence of CA2+ (Intermediate State)
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 4 of NHTMEM16 Lipid Scramblase in Lipid Nanodiscs with MSP2N2 Scaffold Protein in the Presence of CA2+ (Intermediate State) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca802
b:20.8
occ:1.00
|
OE1
|
B:GLU535
|
2.3
|
17.6
|
1.0
|
ND2
|
B:ASN448
|
2.4
|
29.3
|
1.0
|
CG
|
B:ASN448
|
2.8
|
29.3
|
1.0
|
CD
|
B:GLU535
|
3.4
|
17.6
|
1.0
|
OD1
|
B:ASN448
|
3.4
|
29.3
|
1.0
|
CB
|
B:ASN448
|
3.5
|
29.3
|
1.0
|
OD1
|
B:ASN531
|
3.6
|
18.4
|
1.0
|
O
|
B:ASN448
|
3.7
|
29.3
|
1.0
|
OE2
|
B:GLU535
|
3.8
|
17.6
|
1.0
|
OE1
|
B:GLU452
|
3.9
|
30.9
|
1.0
|
ND2
|
B:ASN531
|
4.1
|
18.4
|
1.0
|
C
|
B:ASN448
|
4.2
|
29.3
|
1.0
|
CG
|
B:ASN531
|
4.3
|
18.4
|
1.0
|
OE1
|
B:GLU506
|
4.4
|
14.7
|
1.0
|
CA
|
B:ASN448
|
4.4
|
29.3
|
1.0
|
CG
|
B:GLU535
|
4.6
|
17.6
|
1.0
|
CB
|
B:GLU535
|
4.8
|
17.6
|
1.0
|
CD
|
B:GLU452
|
4.9
|
30.9
|
1.0
|
N
|
B:PHE449
|
5.0
|
31.0
|
1.0
|
|
Reference:
Z.Feng,
O.E.Alvarenga,
A.Accardi.
Structural Basis of Closed Groove Scrambling By A TMEM16 Protein. Nat.Struct.Mol.Biol. 2024.
ISSN: ESSN 1545-9985
PubMed: 38684930
DOI: 10.1038/S41594-024-01284-9
Page generated: Fri Jul 19 12:07:11 2024
|